Optiver Holding’s Evotec EVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$709K Buy
283,576
+242,973
+598% +$783K ﹤0.01% 598
2025
Q4
$125K Buy
+40,603
New +$139K ﹤0.01% 786
2025
Q1
Sell
-2,543
Closed -$10.6K 1414
2024
Q4
$10.6K Buy
+2,543
New +$10.7K ﹤0.01% 750
2024
Q2
Sell
-41,507
Closed -$325K 929
2024
Q1
$325K Sell
41,507
-39,303
-49% -$309K ﹤0.01% 455
2023
Q4
$945K Buy
80,810
+69,936
+643% +$686K ﹤0.01% 369
2023
Q3
$107K Sell
10,874
-23,082
-68% -$271K ﹤0.01% 443
2023
Q2
$380K Buy
33,956
+5,881
+21% +$62.8K ﹤0.01% 382
2023
Q1
$298K Buy
28,075
+6,599
+31% +$63.1K ﹤0.01% 394
2022
Q4
$174K Buy
+21,476
New +$188K ﹤0.01% 354
2022
Q3
Sell
-165,234
Closed -$1.98M 409
2022
Q2
$1.98M Buy
165,234
+162,934
+7,084% +$2.13M ﹤0.01% 219
2022
Q1
$35K Buy
+2,300
New +$39.3K ﹤0.01% 332

Other funds holding EVO

Optiver Holding's EVO Position: Q1 2026 in Review

Optiver Holding increased its Evotec (EVO) stake by 598% in Q1 2026, buying an estimated $783K and bringing the position to 283,576 shares worth $709K. The position accounts for ﹤0.01% of the portfolio, ranked #598.

Optiver Holding first reported a position in EVO in Q1 2022 and has held it in 11 quarters since. The position peaked at $1.98M in Q2 2022. 46 funds tracked by Wall St. Rank hold EVO as of Q1 2026.

  • Optiver Holding held 283,576 shares of Evotec worth $709K as of Q1 2026.
  • Optiver Holding bought 242,973 Evotec shares in Q1 2026, an estimated $783K.
  • Evotec made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #598 holding.
  • Optiver Holding first reported a position in Evotec in Q1 2022 and has held it in 11 quarters since.
  • Optiver Holding's Evotec position peaked at $1.98M in Q2 2022.
  • 46 funds tracked by Wall St. Rank held Evotec as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.